New York Life Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Sell |
10,748
-26
| -0.2% | -$5.69K | 0.02% | 500 |
|
|
2025
Q1 | $2.41M | Sell |
10,774
-51
| -0.5% | -$11.4K | 0.02% | 494 |
|
|
2024
Q4 | $3.55M | Buy |
10,825
+84
| +0.8% | +$27.5K | 0.03% | 412 |
|
|
2024
Q3 | $3.22M | Sell |
10,741
-375
| -3% | -$113K | 0.03% | 453 |
|
|
2024
Q2 | $3.66M | Sell |
11,116
-43
| -0.4% | -$14.2K | 0.04% | 413 |
|
|
2024
Q1 | $4.42M | Sell |
11,159
-391
| -3% | -$155K | 0.04% | 366 |
|
|
2023
Q4 | $4.07M | Buy |
11,550
+88
| +0.8% | +$31K | 0.04% | 367 |
|
|
2023
Q3 | $4.3M | Sell |
11,462
-114
| -1% | -$42.8K | 0.05% | 337 |
|
|
2023
Q2 | $4.43M | Sell |
11,576
-36
| -0.3% | -$13.8K | 0.05% | 343 |
|
|
2023
Q1 | $4.02M | Sell |
11,612
-7,538
| -39% | -$2.61M | 0.04% | 359 |
|
|
2022
Q4 | $4.51M | Sell |
19,150
-181
| -0.9% | -$42.6K | 0.05% | 348 |
|
|
2022
Q3 | $4.76M | Sell |
19,331
-445
| -2% | -$109K | 0.06% | 319 |
|
|
2022
Q2 | $5.98M | Buy |
+19,776
| New | +$5.98M | 0.07% | 276 |
|